Sandeep Gurbuxani to Fluorodeoxyglucose F18
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Fluorodeoxyglucose F18.
Connection Strength
0.131
-
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review. J Gastrointest Cancer. 2007; 38(1):19-23.
Score: 0.066
-
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review. J Gastrointest Cancer. 2007; 38(1):59-62.
Score: 0.066